Patent Application
Utility
App. No. 19/178,730
· Confirmation No. 6690
Method of Adjuvant Cancer Treatment
Applicant:
Novartis Pharmaceuticals Corporation
Docketed New Case - Ready for Examination
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2026-07-23 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2026-04-16 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2026-04-16 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2026-04-07 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2026-04-07 | PEFR |
Applicant Response to Pre-Exam Formalities Notice | 2 | View | |
| 2026-04-07 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2025-09-10 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2025-09-10 | NTC.MISS.PRT |
Notice to File Missing Parts | 2 | View | |
| 2025-09-10 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2025-09-10 | WELCOME.LET |
Welcome Letter from USPTO Director and Deputy Director | 1 | View | |
| 2025-07-25 | CFILE |
Request for Corrected Filing Receipt | 2 | View | |
| 2025-07-25 | ADS |
Application Data Sheet | 9 | View | |
| 2025-07-25 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2025-07-25 | TRAN.LET |
Transmittal Letter | 3 | View | |
| 2025-07-25 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2025-07-25 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 9 | View | |
| 2025-04-14 | SPEC |
Specification | — | View | |
| 2025-04-14 | SPEC |
Specification | 18 | View | |
| 2025-04-14 | CLM |
Claims | 1 | View | |
| 2025-04-14 | ABST |
Abstract | 1 | View | |
| 2025-04-14 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2025-04-14 | PA.. |
Power of Attorney | 1 | View | |
| 2025-04-14 | OATH |
Oath or Declaration filed | 2 | View | |
| 2025-04-14 | ADS |
Application Data Sheet | 9 | View |
Inventors
Sylvie LAQUERRE
King of Prussia, PA
Peter F. LEBOWITZ
Research Triangle Park, NC
Attorneys & Agents of Record
Classification
USPC
514/264.1
A61K31/519
A61P43/00
A61P17/00
A61P35/00
A61K31/506
A61K2300/00
Prosecution
- Examiner
- CENTRAL, DOCKET
- Art Unit
- 1629
- Customer No.
- 75074
- Docket No.
- PAT056650-US-CNT06
- Confirmation No.
- 6690
Publication
- Pub. No.
- US20260207608A1
- Pub. Date
- 2026-07-23
Parent
is a Continuation of
→
App. 18/062,764
Filed 2022-12-07
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Continuation of
→
App. 17/095,200
Filed 2020-11-11
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Continuation of
→
App. 16/664,978
· US 10,869,869
Filed 2019-10-28
· Patented Case
Parent
is a Continuation of
→
App. 16/056,702
Filed 2018-08-07
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Continuation of
→
App. 15/479,663
Filed 2017-04-05
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Continuation of
→
App. 14/422,182
Filed 2015-02-18
· Abandoned -- Failure to Respond to an Office Action
Parent
PCT
is a National Stage Entry of
→
PCT/US2013/057432
Filed 2013-08-30
· Docketed New Case - Ready for Examination
Parent
Claims priority from a provisional application
→
App. 61/696,375
Filed 2012-09-04
· Provisional Application Expired
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2025-05-01
from
NOVARTIS AG
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2025-05-01
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 19/178,730
- Filed
- 2025-04-14
- Pub. No.
- US20260207608A1
- Examiner
- CENTRAL, DOCKET
- Art Unit
- 1629
External Links